Status:
COMPLETED
Single Shot Versus OnQ Pump in Extremity Fractures
Lead Sponsor:
NYU Langone Health
Conditions:
Pain
Fracture
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Peripheral nerve blocks have been well studied in the literature with generally good results for controlling post operative pain following orthopaedic surgery. Regional anesthesia has many benefits. I...
Detailed Description
Purpose The purpose of this randomized prospective study will be to compare post-operative pain control after extremity fracture fixation surgery between patients who receive single shot versus contin...
Eligibility Criteria
Inclusion
- Patients at least 18 years old.
- Male or Female
- All racial and ethnic groups
- Fractures and fracture/dislocations of the foot, ankle, tibia, fibula, elbow, forearm, wrist and hand
- Patients who opt for surgical treatment of their fractures.
- Patients who consent to be randomized.
- Patients who are willing to follow-up for a minimum of 52 weeks.
Exclusion
- Patients younger than 18 years old.
- Patients who are on chronic opioids
- Patients who abuse opioids
- Patients who are unwilling to follow-up for a minimum of 52 weeks.
- Neurologic condition that could interfere with pain sensation
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02280291
Start Date
August 1 2013
End Date
December 13 2018
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Joint Diseases
New York, New York, United States, 10003